Results 151 to 160 of about 47,907 (235)

Insights into the microbiome of breast implants and periprosthetic tissue in breast implant-associated anaplastic large cell lymphoma [PDF]

, 2019
Clemens, Mark W., Hanson, Blake M., Hultgren, Scott J., Myckatyn, Terence M., Parikh, Rajiv, Pinkner, Chloe L., Pinkner, Jerome S., Simar, Shelby R., Walker, Jennifer N.   +8 more
core   +1 more source

GANT61 suppresses proliferation and induces apoptosis in ALK-Positive anaplastic large cell lymphoma via modulating the Hh-PIK3IP1-Akt signaling axis. [PDF]

Ann Hematol
Chen H, Gao J, Li C, Han Y, Liu S, Zhu X.   +5 more
europepmc   +1 more source

PRDM1 expression levels in marginal zone lymphoma and lymphoplasmacytic lymphoma [PDF]

, 2017
Hassan, Anjum, Hussaini, Mohammad, Mirza, Abu-Sayeef, Pfeifer, John, Yeung, Cecilia, Zhu, Xiaopei   +5 more
core   +1 more source

Corrigendum: Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma. [PDF]

Front Oncol
Salah A, Hafez H, Semary S, Khorshed EN, Soliman S, Zaky I, Shahin SM, Lehmann L, ElHaddad A.   +8 more
europepmc   +1 more source

High-Throughput Molecular Characterization of the Microbiome in Breast Implant-Associated Anaplastic Large Cell Lymphoma and Peri-Implant Benign Seromas. [PDF]

Cancers (Basel)
Rogges E, Bertolazzi G, Vacca D, Borro M, Lopez G, Simmaco M, Scattone A, Firmani G, Sorotos M, Santanelli di Pompeo F, Noccioli N, Savino E, Vecchione A, Di Napoli A.   +13 more
europepmc   +1 more source

Molecular Insights into the Diagnosis of Anaplastic Large Cell Lymphoma: Beyond Morphology and Immunophenotype. [PDF]

Int J Mol Sci
Frutos Díaz-Alejo J, Prieto-Potín I, Manso R, Rodríguez M, Rebollo-González M, Díaz de la Pinta FJ, Morales-Gallego M, Rodríguez-Pinilla SM, Onaindia A.   +8 more
europepmc   +1 more source

Anaplastic Large Cell Lymphoma of the Breast by Race and Ethnicity.

JAMA Netw Open
Kim DK, Lowe LS, Neugut AI, Yu JB, Cheng SK, Kachnic LA, Horowitz DP, Rohde CH, Kinslow CJ.   +8 more
europepmc   +1 more source

BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphoma. [PDF]

Blood Adv
Pignataro C, Zoppoli P, Cappelli LV, Yoffe L, Moretti M, Izzo M, Mallia S, Kayembe C, Taylor A, Petrillo G, Affinito A, Quintavalle C, De Luca G, Mascolo M, Verde S, Fraticelli A, Ciarrocchi A, Salerno P, De Smaele E, Campese AF, Fragliasso V, Foà R, Merla G, Inghirami G, Condorelli G, Fiore D.   +25 more
europepmc   +1 more source

Impact of CD3 expression on outcome in pediatric anaplastic large cell lymphoma. [PDF]

Front Oncol
Salah A, Hafez H, Semary S, Nageb E, Soliman S, Zaky I, Shahin SM, Lehmann L, ElHaddad A.   +8 more
europepmc   +1 more source

Correction: Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years' follow-up. [PDF]

Blood Cancer J
Domingo-Domènech E, Pro B, Illidge T, Horwitz S, Trumper L, Iyer S, Advani R, Bartlett NL, Christensen JH, Kim WS, Feldman T, Choi I, Gritti G, Belada D, Shustov A, Illes A, Zinzani PL, Hüttmann A, Trneny M, Le Gouill S, Jagadeesh D, Friedberg JW, Little M, Dong C, Fanale M, Fenton K, Savage KJ.   +26 more
europepmc   +1 more source